Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 150
Selected: 0
NCT IDTitle
NCT05851027Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia
NCT06880276Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT06911827A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
NCT05920876A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma
NCT05458076A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants
NCT06760676A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy
NCT06898060To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture
NCT06932094Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors
NCT06884891A Phase Ⅲ Comparative Study of QL2108 to Dupixent®
NCT06047431A Study of QL1706H in Patients With Advanced Solid Tumors
NCT05799820QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC
NCT04864782QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
NCT05716126Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male Volunteers
NCT03435666A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition
NCT06754644A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
NCT05823246Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma
NCT06613880Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
NCT05309629Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer
NCT03557580A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects
NCT04326829QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors
NCT04296994A Study of QL1706 in Subjects With Advanced Malignant Tumor
NCT04234594Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
NCT05801094A Phase I Study of QL1604 for Advanced Solid Tumors
NCT05487391A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
NCT06872580A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors
NCT06742138To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma
NCT04527068QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer
NCT00404989Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT05329025A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer
NCT06936748Study of SFRT+Sequential Hypofractionated/Conventional RT+Ipilimumab Tuvorilimab for Recurrent/Refractory Solid Tumors
NCT05860530Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers
NCT06671548Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
NCT04157257An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy
NCT03381430Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR
NCT05531994Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy Volunteers
NCT05621330Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia
NCT06403735A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
NCT02908958Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
NCT06686576A Study of Perioperative QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
NCT04486430Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset
NCT05703204A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT03195569To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer
NCT05884801Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors
NCT05976568A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
NCT04629846Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.
NCT05648669A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain
NCT05555212To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation
NCT06942767Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
NCT05052567CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma
NCT05576272A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma